However, I will say that I am curious & looking forward to what happens with potential partners due to this statement:
Deitcher said he expects Marqibo to eventually be combined with biologic drugs being developed for treatment of ALL, such as Amgen Inc's experimental antibody blinatumomab.
If there is a synergistic effect of combination therapy and Amgen came courting, you can bet the PPS will be significant.